NO141756C - Analogifremgangsmaate for fremstilling av antiparasittisk aktive salicylanilidderivater - Google Patents

Analogifremgangsmaate for fremstilling av antiparasittisk aktive salicylanilidderivater

Info

Publication number
NO141756C
NO141756C NO760948A NO760948A NO141756C NO 141756 C NO141756 C NO 141756C NO 760948 A NO760948 A NO 760948A NO 760948 A NO760948 A NO 760948A NO 141756 C NO141756 C NO 141756C
Authority
NO
Norway
Prior art keywords
preparation
analogy procedure
antiparasitic active
salicylanilide derivatives
salicylanilide
Prior art date
Application number
NO760948A
Other languages
English (en)
Other versions
NO760948L (no
NO141756B (no
Inventor
Marcel A C Janssen
Victor K Sipido
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO760948L publication Critical patent/NO760948L/no
Publication of NO141756B publication Critical patent/NO141756B/no
Publication of NO141756C publication Critical patent/NO141756C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
    • C07C205/12—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO760948A 1975-03-18 1976-03-18 Analogifremgangsmaate for fremstilling av antiparasittisk aktive salicylanilidderivater NO141756C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55961675A 1975-03-18 1975-03-18
US05/648,681 US4005218A (en) 1975-03-18 1976-01-13 Antiparasitic salicylanilide derivatives

Publications (3)

Publication Number Publication Date
NO760948L NO760948L (no) 1976-09-21
NO141756B NO141756B (no) 1980-01-28
NO141756C true NO141756C (no) 1980-05-07

Family

ID=27072109

Family Applications (1)

Application Number Title Priority Date Filing Date
NO760948A NO141756C (no) 1975-03-18 1976-03-18 Analogifremgangsmaate for fremstilling av antiparasittisk aktive salicylanilidderivater

Country Status (26)

Country Link
US (1) US4005218A (no)
JP (1) JPS6033823B2 (no)
AT (1) AT353779B (no)
BG (1) BG25071A3 (no)
CA (1) CA1076589A (no)
CH (1) CH622774A5 (no)
CS (1) CS193539B2 (no)
DE (1) DE2610837C2 (no)
DK (1) DK155002C (no)
ES (1) ES446222A1 (no)
FI (1) FI63218C (no)
FR (1) FR2304346A1 (no)
GB (1) GB1537929A (no)
HU (1) HU172487B (no)
IE (1) IE42668B1 (no)
IL (1) IL49221A (no)
IT (1) IT1058013B (no)
LU (1) LU74578A1 (no)
NL (1) NL182311C (no)
NO (1) NO141756C (no)
PH (1) PH11535A (no)
PL (1) PL100907B1 (no)
PT (1) PT64912B (no)
SE (1) SE429336B (no)
SU (1) SU728713A3 (no)
YU (1) YU40135B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470979A (en) * 1982-09-17 1984-09-11 Janssen Pharmaceutica N.V. Chemical sterilization of insects with salicylanilides
EP0104677B1 (en) * 1982-09-17 1986-11-12 Janssen Pharmaceutica N.V. Chemical sterilisation of insects with salicyl anilides
DE3401950A1 (de) * 1984-01-20 1985-08-01 Bayer Ag, 5090 Leverkusen Substituierte salicylsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3912100A1 (de) * 1989-04-13 1990-10-25 Bayer Ag Substituierte uracile, verfahren zu ihrer herstellung und verwendung gegen parasitaere protozoen
KR20030064970A (ko) * 2002-01-29 2003-08-06 주식회사 엘지생명과학 신규 살리실아닐라이드 유도체 및 그를 함유하는 항균제조성물
GB2386066A (en) * 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
AU2002952597A0 (en) * 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
GB0316377D0 (en) 2003-07-12 2003-08-13 Norbrook Lab Ltd Parasiticidal composition
US7666444B2 (en) * 2004-02-02 2010-02-23 Wyeth Antiparasitic composition
AR056339A1 (es) * 2005-05-09 2007-10-03 Astrazeneca Ab Derivados benzoicos
CN101218199A (zh) * 2005-05-09 2008-07-09 阿斯利康(瑞典)有限公司 新化合物ⅰ
PA8783901A1 (es) * 2007-06-15 2009-01-23 Janssen Pharmaceutica Nv Derivados antihelmínticos de benzo(d)isoxazolil benzamida
CN102180811B (zh) * 2011-03-23 2013-12-04 浙江荣耀化工有限公司 一种氯氰碘柳胺钠中间体的催化加氢制备方法
CN103172537A (zh) * 2013-03-19 2013-06-26 常州亚邦齐晖医药化工有限公司 一锅法制备2-（4-氨基-2-氯5-甲基苯基）-2-（4-氯苯基）乙腈
CN103172536A (zh) * 2013-03-19 2013-06-26 常州亚邦齐晖医药化工有限公司 4-氨基-2,6-二氯-α-（4-氯苯基）苯乙腈的制备方法
CN104945282A (zh) * 2015-05-10 2015-09-30 洪志 一种超声促进的4-氯-α-(2-氯-4-(羟亚胺基)-5-甲基-2,5-亚环己二烯基)苯乙腈催化转移氢化还原方法
US10995061B2 (en) * 2018-10-02 2021-05-04 United States Government As Represented By The Department Of Veterans Affairs SPAK kinase inhibitors as neuroprotective agents
CN109851526A (zh) * 2018-12-24 2019-06-07 浙江工业大学上虞研究院有限公司 氯氰碘柳胺钠的制备方法
WO2023242106A1 (en) 2022-06-13 2023-12-21 KHR Biotec GmbH Novel ras inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL27982A (en) * 1966-06-07 1971-06-23 Merck & Co Inc Substituted salicylanilides and methods of preparing same
US3798258A (en) * 1970-03-13 1974-03-19 Merck & Co Inc Salicylanilides

Also Published As

Publication number Publication date
AT353779B (de) 1979-12-10
CA1076589A (en) 1980-04-29
ES446222A1 (es) 1977-12-01
NL182311C (nl) 1988-02-16
HU172487B (hu) 1978-09-28
DK155002C (da) 1989-06-12
SU728713A3 (ru) 1980-04-15
PT64912A (fr) 1976-04-01
BG25071A3 (en) 1978-07-12
NL7602716A (nl) 1976-09-21
DE2610837C2 (de) 1985-10-03
YU40135B (en) 1985-08-31
ATA199276A (de) 1979-05-15
LU74578A1 (no) 1976-09-01
PT64912B (fr) 1978-03-24
CH622774A5 (no) 1981-04-30
IE42668L (en) 1976-09-18
GB1537929A (en) 1979-01-10
IT1058013B (it) 1982-04-10
NL182311B (nl) 1987-09-16
YU67576A (en) 1982-08-31
PH11535A (en) 1978-03-10
FR2304346B1 (no) 1978-11-17
IL49221A (en) 1979-10-31
DK116576A (da) 1976-09-19
JPS6033823B2 (ja) 1985-08-05
DK155002B (da) 1989-01-23
SE7601960L (sv) 1976-09-19
FI760705A (no) 1976-09-19
DE2610837A1 (de) 1976-09-30
CS193539B2 (en) 1979-10-31
JPS51115451A (en) 1976-10-12
PL100907B1 (pl) 1978-11-30
AU1210376A (en) 1977-09-22
IE42668B1 (en) 1980-09-24
SE429336B (sv) 1983-08-29
NO760948L (no) 1976-09-21
FI63218B (fi) 1983-01-31
IL49221A0 (en) 1976-05-31
FR2304346A1 (fr) 1976-10-15
NO141756B (no) 1980-01-28
US4005218A (en) 1977-01-25
FI63218C (fi) 1983-05-10

Similar Documents

Publication Publication Date Title
NO147450C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
SE433208B (sv) Forfarande for framstellning av fenoletrar
NO141411C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive erytromycin-derivater
NO151411C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO141756C (no) Analogifremgangsmaate for fremstilling av antiparasittisk aktive salicylanilidderivater
NO145792C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidon-derivater
NO151040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
SE7605139L (sv) Forfarande for framstellning av vattenupptagande cellulosaetrar
NO146022C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme benzofenonderivater
SE426065B (sv) Forfarande for framstellning av nikotinsyraamid
NO143903C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater
SE428688B (sv) Forfarande for framstellning av nya antidiabetiskt aktiva isooxazolderivat
SE7606116L (sv) Forfarande for framstellning av 3-fenoxidbensaldehyder
SE427841B (sv) Analogiforfarande for framstellning av tienamycinderivat
NO144741C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiopyrano-pyrazoler
SE7604781L (sv) Forfarande for framstellning av diarylhydroxibutylaminer
NO144019C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive naftyridinderivater
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
NO143993C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive guanidinderivater
SE427840B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE7610968L (sv) Forfarande for framstellning av biologiskt aktiva di-karboxylsyraderivat
NO145538C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive morfantridin-forbindelser
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner
SE7610637L (sv) Forfarande for framstellning av 2-alkylindaner